-
Fund Dashboard
- Holdings
Pharmaceuticals
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
SOCIETE GENERALE | 124.00 k | 124.00 k principal | 4.00 | Repurchase agreement | Long | USA |
HSBC SECURITIES USA INC | 118.00 k | 118.00 k principal | 3.80 | Repurchase agreement | Long | USA |
CREDIT AGRICOLE CIB NY | 111.00 k | 111.00 k principal | 3.58 | Repurchase agreement | Long | USA |
Natwest Markets PLC | 111.00 k | 111.00 k principal | 3.58 | Repurchase agreement | Long | USA |
AXSM Axsome Therapeutics, Inc. | 106.08 k | 1.22 k shares | 3.42 | Common equity | Long | USA |
VTRS Viatris Inc. | 106.03 k | 8.79 k shares | 3.42 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 103.91 k | 1.32 k shares | 3.35 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 103.25 k | 2.17 k shares | 3.33 | Common equity | Long | USA |
PFE Pfizer Inc. | 99.22 k | 3.25 k shares | 3.20 | Common equity | Long | USA |
CORT Corcept Therapeutics Incorporated | 98.11 k | 2.54 k shares | 3.16 | Common equity | Long | USA |
JNJ Johnson & Johnson | 96.92 k | 614.00 shares | 3.13 | Common equity | Long | USA |
OGN Organon & Co. | 95.83 k | 4.38 k shares | 3.09 | Common equity | Long | USA |
CTLT Catalent, Inc. | 95.66 k | 1.61 k shares | 3.08 | Common equity | Long | USA |
ZTS Zoetis Inc. | 94.52 k | 525.00 shares | 3.05 | Common equity | Long | USA |
PRGO Perrigo Company plc | 94.17 k | 3.33 k shares | 3.04 | Common equity | Long | Ireland |
RPRX Royalty Pharma plc | 93.55 k | 3.32 k shares | 3.02 | Common equity | Long | UK |
JAZZ Jazz Pharmaceuticals plc | 87.32 k | 792.00 shares | 2.82 | Common equity | Long | Ireland |
LLY Eli Lilly and Company | 81.23 k | 101.00 shares | 2.62 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 79.78 k | 2.90 k shares | 2.57 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 78.06 k | 690.00 shares | 2.52 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 67.02 k | 7.92 k shares | 2.16 | Common equity | Long | USA |
ELAN Elanco Animal Health Incorporated | 64.68 k | 4.96 k shares | 2.09 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc. | 57.50 k | 812.00 shares | 1.85 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 55.62 k | 1.28 k shares | 1.79 | Common equity | Long | USA |
SAVA Cassava Sciences, Inc. | 55.51 k | 2.50 k shares | 1.79 | Common equity | Long | USA |
ROYAL BANK OF CANADA | 55.00 k | 55.00 k principal | 1.77 | Repurchase agreement | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 53.92 k | 1.40 k shares | 1.74 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 50.37 k | 1.69 k shares | 1.62 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 50.24 k | 461.00 shares | 1.62 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 42.65 k | 1.28 k shares | 1.38 | Common equity | Long | USA |
Invesco Government & Agency Portfolio | 41.81 k | 41.81 k shares | 1.35 | Short-term investment vehicle | N/A | USA |
TARS Tarsus Pharmaceuticals, Inc. | 40.32 k | 1.66 k shares | 1.30 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 40.12 k | 1.19 k shares | 1.29 | Common equity | Long | USA |
MNMD Mind Medicine (MindMed) Inc. | 35.54 k | 3.84 k shares | 1.15 | Common equity | Long | Canada |
ANIP ANI Pharmaceuticals, Inc. | 34.63 k | 527.00 shares | 1.12 | Common equity | Long | USA |
UMB FINANCIAL CORP | 34.00 k | 34.00 k principal | 1.10 | Repurchase agreement | Long | USA |
PCRX Pacira BioSciences, Inc. | 33.99 k | 1.65 k shares | 1.10 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 33.53 k | 1.97 k shares | 1.08 | Common equity | Long | USA |
INVA Innoviva, Inc. | 32.44 k | 1.72 k shares | 1.05 | Common equity | Long | USA |
Liquidia Corporation | 31.34 k | 2.63 k shares | 1.01 | Common equity | Long | USA |
AMRX Amneal Pharmaceuticals, Inc. | 28.04 k | 3.83 k shares | 0.90 | Common equity | Long | USA |
EOLS Evolus, Inc. | 26.77 k | 2.15 k shares | 0.86 | Common equity | Long | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX
GOLDMAN SACHS GROUP, INC
|
25.19 k | 195.00 other units | 0.81 | Equity derivative | N/A | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 23.05 k | 2.33 k shares | 0.74 | Common equity | Long | USA |
HROW Harrow Health, Inc. | 22.48 k | 872.00 shares | 0.72 | Common equity | Long | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX
UBS SECURITIES LLC
|
21.01 k | 208.00 other units | 0.68 | Equity derivative | N/A | USA |
ELVN Enliven Therapeutics, Inc. | 19.10 k | 724.00 shares | 0.62 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 18.59 k | 1.30 k shares | 0.60 | Common equity | Long | USA |
FULC Fulcrum Therapeutics, Inc. | 17.78 k | 1.92 k shares | 0.57 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 13.74 k | 3.59 k shares | 0.44 | Common equity | Long | USA |
WVE Wave Life Sciences Ltd. | 11.87 k | 1.80 k shares | 0.38 | Common equity | Long | Singapore |
XERS Xeris Pharmaceuticals Inc | 10.75 k | 4.33 k shares | 0.35 | Common equity | Long | USA |